Clinical Trial Update: Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine [Phase 2]

View source ↗

Summary

Phase 2 trial update on antiviral activity and resistance of lamivudine in combination with other nucleoside analogs for HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Didanosine (didanosine)
• Lamivudine (lamivudine)
• Zidovudine (Zidovudine)
• stavudine (stavudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED